Home/Filings/4/0001595585-20-000126
4//SEC Filing

Otto Dawn Parsell 4

Accession 0001595585-20-000126

CIK 0001595585other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 8:46 PM ET

Size

5.2 KB

Accession

0001595585-20-000126

Insider Transaction Report

Form 4
Period: 2020-09-10
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
  • Award

    Common Stock

    2020-09-10+4,0004,637 total
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") that vest on December 31, 2021, subject to the Reporting Person's continuous service through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock.
  • [F2]This amount includes 382 shares acquired on June 30, 2020 under the Tricida, Inc. 2018 Employee Stock Purchase Plan. This acquisition is exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from Section 16(a) pursuant to Rule 16a-3(f)(1)(i)(B).

Issuer

Tricida, Inc.

CIK 0001595585

Entity typeother

Related Parties

1
  • filerCIK 0001748808

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 8:46 PM ET
Size
5.2 KB